FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 8.067
AS - Asia 5.277
EU - Europa 2.917
SA - Sud America 2.890
AF - Africa 183
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 18
Totale 19.375
Nazione #
US - Stati Uniti d'America 7.887
BR - Brasile 2.588
SG - Singapore 2.037
CN - Cina 1.783
UA - Ucraina 1.120
HK - Hong Kong 457
DE - Germania 416
VN - Vietnam 363
IT - Italia 362
FR - Francia 271
FI - Finlandia 192
SE - Svezia 182
GB - Regno Unito 141
AR - Argentina 109
TR - Turchia 84
IQ - Iraq 77
CA - Canada 72
IN - India 70
ZA - Sudafrica 57
BD - Bangladesh 56
MX - Messico 53
EC - Ecuador 48
UZ - Uzbekistan 48
RU - Federazione Russa 46
VE - Venezuela 44
PK - Pakistan 43
KR - Corea 38
MA - Marocco 34
BE - Belgio 33
CO - Colombia 29
JP - Giappone 25
PL - Polonia 24
ID - Indonesia 21
KE - Kenya 21
NP - Nepal 20
PE - Perù 20
ES - Italia 18
NL - Olanda 18
AU - Australia 17
EU - Europa 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
PY - Paraguay 16
DZ - Algeria 15
EG - Egitto 14
JO - Giordania 14
PH - Filippine 14
KZ - Kazakistan 13
UY - Uruguay 13
DO - Repubblica Dominicana 11
JM - Giamaica 11
LB - Libano 11
AZ - Azerbaigian 10
GR - Grecia 10
KG - Kirghizistan 10
OM - Oman 10
AT - Austria 9
CZ - Repubblica Ceca 9
IL - Israele 8
AL - Albania 7
CR - Costa Rica 7
DK - Danimarca 7
LT - Lituania 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
BG - Bulgaria 6
BO - Bolivia 6
HN - Honduras 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
HR - Croazia 5
MY - Malesia 5
NI - Nicaragua 5
AM - Armenia 4
AO - Angola 4
CI - Costa d'Avorio 4
GE - Georgia 4
GT - Guatemala 4
IE - Irlanda 4
IR - Iran 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
CG - Congo 3
CH - Svizzera 3
ET - Etiopia 3
LU - Lussemburgo 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
Totale 19.351
Città #
Dallas 2.494
Singapore 1.095
Chandler 1.028
Jacksonville 684
Hong Kong 454
San Jose 442
Ashburn 382
Princeton 356
Beijing 322
Nanjing 294
New York 214
São Paulo 208
Dearborn 172
Lauterbourg 165
Wilmington 147
Sassari 143
Nanchang 134
Ho Chi Minh City 125
Shanghai 111
Ann Arbor 102
Boardman 98
Los Angeles 89
Shenyang 85
Hanoi 84
Rio de Janeiro 78
Tianjin 72
Hebei 71
Changsha 68
Santa Clara 68
Belo Horizonte 67
Jiaxing 47
Woodbridge 45
Tashkent 44
Campinas 41
Curitiba 40
Andover 39
Buffalo 39
Jinan 39
Seoul 38
Orem 37
Zhengzhou 37
Baghdad 35
Brasília 35
Ningbo 34
Porto Alegre 34
San Francisco 34
Brussels 33
Johannesburg 32
Kunming 31
Mountain View 31
Izmir 29
Toronto 29
Hangzhou 28
Salvador 25
Norwalk 24
Tokyo 24
Warsaw 24
Cagliari 22
Guarulhos 22
Ribeirão Preto 22
Guangzhou 21
Haiphong 21
Brooklyn 20
Council Bluffs 20
London 20
Montreal 20
Fortaleza 19
Goiânia 19
Manaus 19
Nairobi 19
Sorocaba 18
Denver 17
Frankfurt am Main 17
Helsinki 17
Santo André 17
Campo Grande 16
Da Nang 16
Guayaquil 16
Juiz de Fora 16
Manchester 16
Osasco 16
Quito 16
Chennai 15
Mumbai 15
Recife 15
São José dos Campos 15
Taizhou 15
Atlanta 14
Boston 14
Dhaka 14
Lima 14
Mauá 14
Stockholm 14
São Gonçalo 14
Ankara 13
Aracaju 13
Bragança Paulista 13
Casablanca 13
Istanbul 13
Phoenix 13
Totale 11.493
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 218
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 201
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 191
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 191
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 184
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 184
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 180
Apolipoprotein Profiles in Atherosclerotic Disease 177
Apolipoprotein profiles in atherosclerotic disease 170
A study of the switch of fetal hemoglobin in newborn erytrocytes fractionated by density gradient. 166
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 159
Biodiversità marina della Sardegna: prospettive di valorizzazione e sfruttamento sostenibile dei poriferi 159
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 158
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 158
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 157
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 154
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 154
Apolipoprotein Profiles in Atherosclerotic Disease 153
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 151
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 148
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 147
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 147
Differential proteomic analysis of human atherosclerotic plaque extracts 143
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 143
Apolipoprotein profiles in atherosclerotic disease 142
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 139
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 137
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 136
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 135
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 135
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 135
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 134
Buoyant density of Lp(a) subclasses in hypercholesterolemia 134
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 133
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 132
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 132
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 131
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 130
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 130
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 130
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 130
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 127
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 126
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 126
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 125
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 125
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 123
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 121
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 121
A comparative study of the insolubilization of low density lipoproteins by two different families of aortic proteoglycans 120
Sulphated polysaccharide content and localization in some marine sponge species. 119
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 119
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 119
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 118
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 118
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 117
Identification and characterization of biomarkers in atherosclerosis and diabetes. 115
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 114
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 114
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 113
Hb Hamilton [beta11(A8)Val->Ile] in Sardinia. 110
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 109
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 109
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 108
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 107
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 105
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 105
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 105
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 105
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 104
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 104
Glycosamynoglycan diversity in sponge extracellular matrix 104
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 103
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 102
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 101
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 101
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 101
Atherosclerotic modifications of human proteoglycans 101
Urine bikunin as a marker of renal impairment in Fabry's disease 101
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 100
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 100
Lipoprotein(a) and the arterial wall 99
GAG and protein composition of GAG-protein complexes from normal human plasma 99
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 99
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 98
Factors affecting S-homocysteinylation of LDL apoprotein B 98
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 97
Protein oxidation in unstable plaque extracts from human carotid segments 97
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 97
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 96
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 96
Role of the small proteoglycan bikunin in human reproduction 96
Chromatin microfluorometry and energy status of primary cultures of adult rat hepatocytes: Effects of testosterone and dexamethasone 95
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 94
Modifications of low density lipoprotein induced by the interaction with heparin, chondroitin 6 sulphate and plasma high charge GAG-protein complexes 94
Brain interstitial fluid and intracellular distribution of phenytoin 94
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 94
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 94
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 93
Urinary excretion of GAGs during hypocholesterolemic therapy 93
Totale 12.556
Categoria #
all - tutte 75.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 0 0 0 0 197 43 21
2021/2022837 110 5 3 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024594 93 41 15 16 133 102 6 32 9 12 76 59
2024/20255.069 32 40 310 56 212 122 320 881 1.955 768 263 110
2025/20266.900 276 1.731 1.126 1.000 680 459 831 273 332 192 0 0
Totale 19.462